Seagen
Seagen is a Bothell, Washington-based company developing antibody-based therapies for the treatment of cancer and autoimmune diseases.
Key facts
| Also Known As | Seattle Genetics, Inc. |
|---|---|
| AngelList URL | https://angel.co/seattle-genetics |
| Legal Name | Seattle Genetics |
| Company Operating Status | Active |
| Crunchbase URL | https://www.crunchbase.com/organization/seattle-genetics |
| Facebook URL | https://www.facebook.com/pages/Seattle-Genetics-Inc/133016816767091 |
| Full Address | Agern Allé 24, DK-2970, Hørsholm, Denmark |
| LinkedIn URL | http://www.linkedin.com/company/seattle-genetics |
| Pitchbook URL | https://pitchbook.com/profiles/company/14170-96 |
| Previous Name | SEATTLE GENETICS INC /WA |
| Public/Private | Public |
| Stock Symbol | SGEN |
| Ticker Symbol | SGEN |
| Twitter URL | https://twitter.com/SeattleGenetics |
| Official Website | http://seagen.com/ |
| Wellfound ID | seattle-genetics |
| Wikidata ID | Q17155112 |
Contact details
Email and phone for Seagen are available to signed-in members of PharmaLyt.
Sign in to view